Absorption |
Blood-Brain Barrier | BBB+ | 0.9533 |
Human Intestinal Absorption | HIA+ | 0.9249 |
Caco-2 Permeability | Caco2- | 0.5221 |
P-glycoprotein Substrate | Non-substrate | 0.8249 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.6201 |
Non-inhibitor | 0.9259 |
Renal Organic Cation Transporter | Non-inhibitor | 0.9505 |
Distribution |
Subcellular localization | Mitochondria | 0.7696 |
Metabolism |
CYP450 2C9 Substrate | Non-substrate | 0.8254 |
CYP450 2D6 Substrate | Non-substrate | 0.8305 |
CYP450 3A4 Substrate | Substrate | 0.5688 |
CYP450 1A2 Inhibitor | Non-inhibitor | 0.8048 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8037 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9281 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7479 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.8067 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9285 |
Excretion |
Toxicity |
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9517 |
Non-inhibitor | 0.9441 |
AMES Toxicity | AMES toxic | 0.8143 |
Carcinogens | Carcinogens | 0.6839 |
Fish Toxicity | Low FHMT | 0.5587 |
Tetrahymena Pyriformis Toxicity | Low TPT | 0.6365 |
Honey Bee Toxicity | High HBT | 0.8798 |
Biodegradation | Ready biodegradable | 0.7555 |
Acute Oral Toxicity | I | 0.7735 |
Carcinogenicity (Three-class) | Non-required | 0.4990 |